# Treatment of Severe Influenza A Infection

> **NCT02108366** · PHASE3 · COMPLETED · sponsor: **The University of Hong Kong** · enrollment: 107 (actual)

## Conditions studied

- Influenza, Human

## Interventions

- **DRUG:** Celecoxib
- **DRUG:** Oseltamivir
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02108366
- **Lead sponsor:** The University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2018-03
- **Final completion:** 2018-06
- **Target enrollment:** 107 (ACTUAL)
- **Last updated:** 2019-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02108366

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02108366, "Treatment of Severe Influenza A Infection". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02108366. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*